Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice
International Journal of Molecular Sciences · 16.10.2023 · 24 (20) · 15237
DOI: 10.3390/ijms242015237 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2023. Verfasst von Seon-Young Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul …. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Parkinson’s disease (PD) is a long-term neurodegenerative disease characterized by dopaminergic neuronal loss and the aggregation of alpha-synuclein (α-syn) in the brain. Cell therapy using regulatory T cells (Tregs) has therapeutic potential on PD progression in a mouse model; however, several challenges were associated with its applications. Here, we propose a strategy for α-syn specific Treg expansion (α-syn Treg). We presented α-syn to T cells via dendritic cells. This method increased the mobility of Tregs towards the site of abundant α-syn in vitro (p < 0.01; α-syn Tregs versus polyclonal Tregs (poly Tregs)) and in vivo. Consequently, α-syn Tregs showed noteworthy neuroprotective effects against motor function deficits (p < 0.05, p < 0.01; α-syn Tregs versus poly Tregs), dopaminergic neuronal loss (p < 0.001; α-syn Tregs versus poly Tregs), and α-syn accumulation (p < 0.05; α-syn Tregs versus poly Tregs) in MPTP-induced PD mice. Furthermore, the adoptive transfer of α-syn Tregs exerted immunosuppressive effects on activated microglia, especially pro-inflammatory microglia, in PD mice. Our findings suggest that α-syn presentation may provide a significant improvement in neuroprotective activities of Tregs and suggest the effective clinical application of Treg therapy in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
- Department of Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
ORCID-Profile: Seon-Young Park, HyeJin Yang, Soyoung Kim, Juwon Yang, Hyunsu Bae
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Park, S. Y., Yang, H., Kim, S., Yang, J., Go, H., & Bae, H. (2023). Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice. International Journal of Molecular Sciences, 24(20), 15237. https://doi.org/10.3390/ijms242015237
Vancouver
Park SY, Yang H, Kim S, Yang J, Go H, Bae H. Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice. International Journal of Molecular Sciences. 2023;24(20):15237. doi:10.3390/ijms242015237
BibTeX
@article{Park2023,
author = {Park, Seon-Young and Yang, HyeJin and Kim, Soyoung and Yang, Juwon and Go, Hyemin and Bae, Hyunsu},
title = {Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15237},
doi = {10.3390/ijms242015237}
}
EUVIMED